Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.10
Bid: 4.70
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.80 (17.021%)
Open: 5.10
High: 5.10
Low: 5.10
Prev. Close: 5.10
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Jan 2015 07:00

RNS Number : 0786C
Totally PLC
14 January 2015
 



14 January 2015

Totally plc

("Totally" or "the Company")

 

Trading update

 

The Board of Totally (AIM: TLY), the provider of a range of services to the healthcare sector, is today providing a post year end trading update.

The continued focus of Totally is on innovative solutions for the management of long-term health conditions and the growth of the business is being led by Wendy Lawrence, CEO. In the past year Totally Health Limited, the Company's wholly owned operating subsidiary, has made significant progress in a number of areas in developing and growing its business with the NHS and other healthcare providers. During 2014, Totally was appointed by 9 new clinical commissioning groups ("CCGs") to undertake clinical health coaching programmes focused on the management of long-term conditions and the pipeline for new contracts remains healthy. In particular, the contracts signed with Waltham Forest, Bedfordshire and Hartlepool and Stockton-on-Tees extended the services provided by Totally into Coronary Heart Disease, Diabetes and Chronic Heart Failure, which are new treatment areas, meaning that Totally now works in four of the UK's top five long-term conditions.

However, in the second half of the year the Company has experienced delays in the signing of new contracts and renewals with a small number of CCGs, a Commissioning Support Unit (CSU) and a specialist healthcare organisation, all of which were expected to contribute revenues in the year ended 31 December 2014. The Board of Totally is confident that these delayed contracts will be successfully executed and will contribute positively to the out-turn for the Company in 2015. Administrative expenses for the year ended 31 December 2014 are in line with current market expectations.

As a result of these contract delays revenue for the year ended 31 December 2014 will be below current market expectations, with net loss for the same period being greater than current market expectations.

During November 2014 and December 2014 the Company made a small profit and was cash generative. The Board of Totally is confident that the contract delays experienced by Totally will not impact on the cash position of the Company moving forward.

Given the continued renewals of existing contracts with CCGs and the pipeline of contracts in place for 2015 with CCGs, the NHS and other healthcare organisations, the Board of Totally remain confident of the prospects for the business for 2015. The Board of Totally believe that the board appointments made over recent months are contributing positively to the Company's corporate development activities and pipeline. The Company is currently exploring several corporate opportunities, which include acquisitions and strategic alliances.

 

Totally Plc / Totally Health Limited

 020 3077 2212

Wendy Lawrence, Chief Executive

Don Baladasan, Finance Director

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 020 3328 5656

Nick Naylor / Nick Athanas / Alex Brearley

Optiva Securities Limited (Joint Broker)

020 3137 1902

Christian Dennis / Jeremy King

Blytheweigh

020 7138 3203

Tim Blythe / Camilla Horsfall

 

Notes to Editors

Totally Health Ltd is focused on the provision of professional clinical health coaching which promotes and facilitates self care. Totally's services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

Totally currently operates contracts with NHS England and 9 Clinical Commissioning Groups across England. Shareholders should note that the National Health Service estimates that £7 out of every £10 spent in England on health and social care is supporting people diagnosed with a Long Term Condition.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVXLFFEFFBBBV
Date   Source Headline
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights
3rd Feb 20234:41 pmRNSExercise of options, director/PDMR & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.